Breaking News on Drug DiscoveryDaily
Thursday 30 August 2007
Forward to a colleague |
|
|
| Breaking News on Drug Discovery |
||
|
||
| Daily
Thursday 30 August 2007 |
Forward to a colleague |
|
|
Product Brochure  Pre-Clinical Contract Research - Free DownloadPharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here Access Full Stories  Micromet sticks to tough cancer targetMicromet is sticking to its research into cell adhesion antibodies to treat breast cancer and other tumours, hoping it will have more luck than GlaxoSmithKline and Centocor's failed attempt... Read Charles River, LAB put their faith in Canada Two big players in the early stage contract research organisation (CRO) arena have announced this week they are expanding their preclinical capabilities in Canada as demand for preclinical testing is rising... Read Sigma-Aldrich jump on the LentiExpress for RNAi screening Sigma-Aldrich has launched a new technology that promises to dramatically simplify and speed-up high-throughput (HT) RNAi screening of the human kinome... Read Chinese scientists given freedom to fail As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according... Read GSK drug could prove unlikely saviour for Vioxx Vioxx (rofecoxib) might have been offered a lifeline with the news that the drug could be used safely, so long as drugs such as GlaxoSmithKline's investigational dyslipidaemia compound are administered at the same... Read |
|
||||||||
All News Headlines for: August | July | June |
||||||||||
 Product BrochureA revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Lonza's China plan taking shape Lonza's $200m (€147m) investment in China is continuing to shape up as the firm announced its new small-scale exclusive synthesis manufacturing plant will be up and running next month... Read Silicon nanowires conduct drugs into cells New research has shown that silicon nanowires can be used to deliver toxic agents into both human and bovine epithelial cell lines, opening up new options for drug targeting and delivery... Read EU approval of new Rebif just what the doctor ordered Merck Serono's new and improved version of its blockbuster multiple sclerosis (MS) drug Rebif (interferon beta-1a) has been approved in the EU, providing a little added protection to the company's MS franchise... Read AstraZeneca's schizophrenia drug gets the nod in the Netherlands AstraZeneca has had its new extended-release formulation of its schizophrenia drug approved in the Netherlands... Read
|
||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
